Ranitidine: Stroke Risk And What You Should Know

can ranitadine cause a stroke

Ranitidine is a medication used to treat and prevent stomach and intestine ulcers, as well as conditions caused by excess stomach acid, such as gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome. It belongs to a class of drugs known as histamine-2 blockers or H2 antagonists, which work by reducing stomach acid production. While ranitidine has been commonly used, concerns about its safety emerged in 2019 when the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in the drug, leading to its withdrawal from markets worldwide.

Ranitidine has been linked to various side effects, including an increased risk of pneumonia, Clostridioides difficile colitis, and, in rare cases, thrombocytopenia. However, there is limited evidence directly linking ranitidine to strokes. While it is not a direct cause of strokes, ranitidine may be used in the prevention of stress ulcers, which are a complication of acute strokes.

Characteristics Values
Can ranitidine cause a stroke? No, but it can increase the occurrence of pneumonia in acute stroke patients.
Brand name Zantac
Drug class H2 antagonists
Use Treat and prevent ulcers in the stomach and intestines; treat gastroesophageal reflux disease (GERD) and Zollinger-Ellison syndrome; treat conditions where the stomach produces too much acid
Administration Oral, injection into a muscle, or injection into a vein
Side effects Headaches, pain or burning sensation if given by injection, slow heart rate, pneumonia, potential masking of stomach cancer, increased risk of Clostridioides difficile colitis, malaise, dizziness, somnolence, insomnia, vertigo, arrhythmias, thrombocytopenia, rash, hair loss, vasculitis
Allergic reaction Hives, difficulty breathing, swelling of face, lips, tongue, or throat
Overdose Lack of coordination, feeling light-headed, fainting
Withdrawal Ranitidine was withdrawn from the market in the United States in April 2020 due to the presence of a probable carcinogen, N-nitrosodimethylamine (NDMA), and concerns about increased cancer risk.

medshun

Ranitidine's effect on the body's vitamin B12 absorption

Ranitidine is a medication used to reduce stomach acid production. It is a member of the H-2 (histamine blocker) family of drugs, which work by preventing the release of acid into the stomach. It is used to treat stomach and duodenal ulcers, gastroesophageal reflux disease, and Zollinger-Ellison syndrome.

While ranitidine can be effective in treating these conditions, it has been found to have several side effects and interactions with other substances in the body. One of the most concerning interactions is its effect on the absorption of vitamin B12.

Vitamin B12 is essential for the body's creation of red blood cells, DNA, and the development of the central nervous system. It is naturally found in animal products like meat and dairy, and the body requires it to function properly. However, the body needs stomach acid to release vitamin B12 from food so that it can be absorbed. This is where ranitidine and other H-2 blockers come into play.

H-2 blocker drugs, including ranitidine, reduce stomach acid. As a result, they are associated with decreased dietary vitamin B12 absorption. This means that people who take these drugs over a long period may be at risk of vitamin B12 deficiency. This deficiency can cause a range of health problems, including depression, nerve damage, and dementia.

The link between H-2 blockers and vitamin B12 deficiency is supported by several studies. One study found that people who took acid-inhibiting drugs, including ranitidine, for two or more years were more likely to have a B12 deficiency. Another study suggested that elderly patients taking H-2 receptor antagonists are more likely to require B12 supplementation than those not taking such drugs.

Fortunately, there are ways to mitigate the risk of vitamin B12 deficiency while taking ranitidine. Since the vitamin B12 found in supplements does not require stomach acid for absorption, people taking H-2 blockers can simply take vitamin B12 supplements to ensure adequate levels. Additionally, lab tests can be done to monitor vitamin B12 levels and detect any potential deficiency.

medshun

Ranitidine's potential to cause pneumonia

Ranitidine is a medication used to treat and prevent ulcers in the stomach and intestines, as well as conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. It is also used to treat gastroesophageal reflux disease (GERD) and other conditions where acid flows back from the stomach into the oesophagus, causing heartburn. It belongs to a group of drugs called histamine-2 blockers, which work by reducing the amount of acid the stomach produces.

Ranitidine has been linked to an increased risk of developing pneumonia, with studies showing that its use can lead to an increased occurrence of pneumonia in hospitalised patients, as well as in adults and children. This risk is particularly notable in very-low-birth-weight neonates, who are already at an increased risk of infection and other health complications.

The potential for Ranitidine to cause pneumonia is a serious concern, as pneumonia can have severe consequences, including chest pain, fever, difficulty breathing, and even death. This risk is further compounded by the fact that Ranitidine is often used to treat conditions that can increase an individual's vulnerability to pneumonia, such as acid reflux and ulcers.

While the mechanism behind Ranitidine's potential to cause pneumonia is not yet fully understood, it is essential for patients taking this medication to be aware of the risk and to consult their doctor if they experience any symptoms indicative of pneumonia. It is also crucial for healthcare providers to carefully consider the benefits and risks of prescribing Ranitidine, especially for individuals who may be more susceptible to developing pneumonia.

In conclusion, while Ranitidine can be an effective treatment for acid-related conditions, its potential to cause pneumonia is a significant concern that requires careful consideration and ongoing research to ensure patient safety.

medshun

Ranitidine's link to an increased risk of Clostridioides difficile colitis

Ranitidine is a medication used to decrease stomach acid production. It was previously sold under the brand name Zantac. In 2019, the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products, resulting in recalls and suspensions. Ranitidine was withdrawn from the United States market in April 2020.

Ranitidine has been linked to an increased risk of Clostridioides difficile colitis. Clostridioides difficile (formerly known as Clostridium difficile) is a gram-positive, spore-forming bacterium that can cause antibiotic-associated diarrhea. It is the leading cause of antibiotic-associated diarrhea worldwide and is often associated with healthcare settings.

The use of antibiotics, particularly broad-spectrum antibiotics, is the most significant risk factor for Clostridioides difficile infection. Antibiotics disturb the balance of gut flora, enabling Clostridioides difficile overgrowth and infection. Ranitidine, as an H2 histamine receptor antagonist, blocks histamine and decreases stomach acid, and may therefore contribute to this disruption of gut flora.

Clostridioides difficile infection can range from asymptomatic carriage to severe diarrhea and conditions like pseudomembranous colitis and toxic megacolon. Symptoms of Clostridioides difficile colitis include mild to moderate watery diarrhea, abdominal pain or cramping, fever, and lower abdominal tenderness. Diagnosis is made through stool testing, and treatment involves discontinuing the causative antibiotics and administering appropriate medication.

The link between ranitidine and Clostridioides difficile colitis highlights the importance of understanding the potential side effects of medications and the role they may play in altering the gut microbiome.

medshun

Ranitidine's association with an increased risk of developing acute gastroenteritis and community-acquired pneumonia in children

Ranitidine is a medication used to decrease stomach acid production. It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It can be administered orally, via injection into a muscle, or via injection into a vein.

Ranitidine has been linked to an increased risk of acute gastroenteritis and community-acquired pneumonia in children. A prospective study found that children treated with gastric acidity (GA) inhibitors, including ranitidine, had a significantly higher rate of acute gastroenteritis and community-acquired pneumonia during a 4-month follow-up period compared to healthy controls. The study also found that GA inhibitor-treated children had an increased rate of these infections when comparing the 4 months before and after enrollment, suggesting that GA suppression may be a major risk factor for infections.

Another study observed 274 very low birth weight (VLBW) infants, 91 of whom had taken ranitidine. The study found that infants treated with ranitidine had a significantly higher risk of infections, necrotizing enterocolitis, and fatal outcomes compared to those who did not receive ranitidine.

The potential mechanisms underlying the increased risk of infections with ranitidine include the direct inhibitory effect of GA inhibitors on leukocyte functions and modifications in the qualitative and quantitative gastrointestinal microflora.

medshun

Ranitidine's ability to cause thrombocytopenia

Thrombocytopenia is a rare but known side effect of taking ranitidine. It is a phenomenon where the platelet count falls to 80% of its normal value, and it may be associated with neutropenia and anaemia. Thrombocytopenia is caused by an idiosyncratic reaction associated with an increase in platelet-induced immunoglobulins and their subsequent clearance by the phagocytic system.

Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine and decreasing the amount of acid released by cells in the stomach. It was commonly used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. However, in 2019, the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products, resulting in recalls and suspension in various countries.

Drug-induced thrombocytopenia usually takes weeks or months to appear but may manifest within 12 hours of drug intake in a sensitised individual. The diagnosis of this critical condition is based on clinical suspicion and is often a diagnosis of exclusion, which can be life-saving for critical patients.

In one case, a 55-year-old female with pustular psoriasis presented with multiple pustules over her extremities, along with fever and vomiting. She was administered roxithromycin, IV ondensetron, paracetamol, and IV ranitidine. Repeat investigations revealed falling WBC and platelet counts. After ruling out other causes of pancytopenia, it was concluded that ranitidine was the cause of this atypical drug reaction, as the patient's condition improved within 72 hours of ranitidine withdrawal.

Frequently asked questions

#

Ranitidine is a medication used to decrease stomach acid production. It was previously sold under the brand name Zantac.

Ranitidine is a histamine-2 blocker, which decreases the amount of acid created by the stomach.

Ranitidine is used to treat and prevent ulcers in the stomach and intestines, and to treat conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome. It is also used to treat gastroesophageal reflux disease (GERD) and heartburn.

There is no evidence that Ranitidine directly causes strokes. However, it has been linked to an increased risk of pneumonia, which is a risk factor for strokes. Additionally, Ranitidine was found to increase the occurrence of pneumonia in acute stroke patients, which could affect their recovery.

Common side effects of Ranitidine include headaches, nausea, vomiting, stomach pain, constipation, and diarrhoea. Serious side effects may include cancer, liver problems, slow heart rate, pneumonia, and masking of stomach cancer symptoms.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment